Marinomed Biotech AG | WebDisclosure

Basculer en Français

10067	Companies
205809	Keywords
136082	Articles
109134	Press releases

Home
Companies
Marinomed Biotech AG

PRESS RELEASE

published on 09/16/2025 at 15:22, 6 months 7 days ago

EQS-Adhoc: Marinomed Biotech AG resolves capital increase excluding statutory subscription rights by issuing 61.607 no-par value bearer shares at an issue price of EUR 17,50 per share
Marinomed Biotech AG resolves capital increase by issuing 61.607 bearer shares at EUR 17,50 per share, excluding statutory subscription rights

Capital Increase Marinomed Biotech AG Subscription Rights Bearer Shares EUR 17,50
BRIEF

published on 09/01/2025 at 12:01, 6 months 22 days ago

Marinomed Biotech AG obtient un accord d'émission d'obligations convertibles de 2,5 millions d'euros

Financement Stratégie D'investissement Droits Des Actionnaires Marinomed Biotech Obligation Convertible
BRIEF

published on 09/01/2025 at 12:01, 6 months 22 days ago

Marinomed Biotech AG Secures EUR 2.5 Million Convertible Bond Agreement

Financing Investment Strategy Shareholder Rights Convertible Bond Marinomed Biotech
PRESS RELEASE

published on 09/01/2025 at 11:56, 6 months 22 days ago

EQS-Adhoc: Marinomed Biotech AG: Agreement on the key terms of the issue of a secured EUR 2.5mn convertible bond
Marinomed Biotech AG announces agreement on key terms for a secured EUR 2.5mn convertible bond issue, including interest rate and conversion price

Marinomed Biotech AG Convertible Bond Secured EUR 2.5mn Key Terms
BRIEF

published on 06/30/2025 at 12:56, 8 months 23 days ago

Marinomed Biotech AG : Perspectives positives dans un contexte de redressement stratégique

Restructuration Financière Marinomed Biotech AG Innovation Biotechnologique Plateforme Marinosolv® Développement Budesolv
BRIEF

published on 06/30/2025 at 12:56, 8 months 23 days ago

Marinomed Biotech AG: Positive Outlook Amidst Strategic Turnaround

Marinomed Biotech AG Financial Restructuring Biotech Innovation Marinosolv® Platform Budesolv Development
PRESS RELEASE

published on 06/30/2025 at 12:51, 8 months 23 days ago

Original-Research: Marinomed Biotech AG (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research initiates coverage on Marinomed Biotech AG with a Buy rating and EUR 50.00 price target. Details of the company's dual business model and lead candidate, Budesolv, are highlighted

First Berlin Equity Research BUY Rating Marinomed Biotech AG Biotech Company Dual Business Model
BRIEF

published on 06/06/2025 at 15:25, 9 months 17 days ago

Marinomed Biotech AG Partners to Launch Budesolv in Switzerland

International Expansion Marinomed Biotech AG Milestone Payments Pharma Partnership Budesolv Switzerland
BRIEF

published on 06/06/2025 at 15:25, 9 months 17 days ago

Marinomed Biotech AG s'associe pour lancer Budesolv en Suisse

Expansion Internationale Marinomed Biotech AG Paiements D'étape Partenariat Pharmaceutique Budesolv Suisse
PRESS RELEASE

published on 06/06/2025 at 15:20, 9 months 17 days ago

Marinomed Biotech AG announces partnership for Budesolv in Switzerland
Marinomed Biotech AG announces partnership with Swiss pharmaceutical company for the development and marketing of Budesolv in Switzerland, enabling milestone payments and royalties

Pharmaceutical Company Partnership Switzerland Marinomed Biotech AG Budesolv

Accesswire

Published on 03/23/2026 at 14:05, 6 hours 11 minutes ago

Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders
Published on 03/23/2026 at 14:00, 6 hours 16 minutes ago

BlackBerry AtHoc Advances Command Center for Faster Response and Tighter Control During Critical Operations
Published on 03/23/2026 at 13:05, 7 hours 11 minutes ago

SouthGobi Announces Disclosable and Connected Transaction Deferral of Payment Obligations Under Convertible Debenture and Amended and Restated Cooperation Agreement
Published on 03/23/2026 at 12:32, 7 hours 44 minutes ago

Sinopec Announced 2025 Annual Results Annual Payout Ratio Reached 81%
Published on 03/23/2026 at 12:30, 7 hours 46 minutes ago

Digi Power X to Announce 2025 Year End Financial Results on March 31st

View all ACCESSWIRE

EQS Group

Published on 03/23/2026 at 19:30, 45 minutes ago

Habitat for Humanity launches Let's Open the Door campaign to drive awareness of global housing need
Published on 03/23/2026 at 19:00, 1 hour 16 minutes ago

PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 16 MARS 2026 au 20 MARS 2026
Published on 03/23/2026 at 18:44, 1 hour 31 minutes ago

Transaction in Own Shares
Published on 03/23/2026 at 18:15, 2 hours ago

ISX Financial EU Plc Announces Corporate Name Change to Xryma Plc
Published on 03/23/2026 at 18:09, 2 hours 7 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares

Les Echos

Published on 03/23/2026 at 19:08, 1 hour 8 minutes ago

Reporting on share buyback transactions carried out between March 16 and March 20, 2026
Published on 03/23/2026 at 19:08, 1 hour 8 minutes ago

Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain entre le 16 et le 20 mars 2026
Published on 03/23/2026 at 18:37, 1 hour 38 minutes ago

ALTAREA : Déclaration d’opérations sur actions propres
Published on 03/23/2026 at 17:45, 2 hours 31 minutes ago

ENGIE will build, own and operate its largest onshore wind farm worldwide in Egypt
Published on 03/23/2026 at 17:45, 2 hours 31 minutes ago

En Égypte, ENGIE va construire et exploiter son plus grand parc éolien terrestre au monde

View all LES ECHOS COMFI WIRE